Skp2 Inhibitors: Novel Anticancer Strategies

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|22|2363-2379

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.22, 2016-08, pp. : 2363-2379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 749-772

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Therapeutic Strategies Based on CDK Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 30, 2013-09 ,pp. : 5327-5332

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C inhibitors as novel anticancer drugs

By Jirousek Michael R   Goekjian Peter G  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S.   Wang C.   Wu K.   Francis R.   Pestell R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A.   Popa C.   Serewko M.M.   Jones S.J.   Dicker A.J.   Dahler A.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite